| RS2548605435 |
MMAB
|
Health Risk |
Pathogenic |
Methylmalonic aciduria, cblB type |
| RS2548609966 |
CPLANE1
|
Health Risk |
Likely pathogenic |
Joubert syndrome and related disorders, Joubert syndrome and related disorders |
| RS2548610961 |
MMAB
|
Health Risk |
Pathogenic |
Methylmalonic aciduria, cblB type |
| RS2548611381 |
DMXL2
|
Health Risk |
Pathogenic |
— |
| RS2548614097 |
MMAB
|
Health Risk |
Likely pathogenic |
Methylmalonic aciduria, cblB type |
| RS2548614128 |
MMAB
|
Health Risk |
Pathogenic |
Methylmalonic aciduria, cblB type |
| RS2548614137 |
MMAB
|
Health Risk |
Likely pathogenic |
Methylmalonic aciduria, cblB type |
| RS2548614273 |
MMAB
|
Health Risk |
Pathogenic |
Methylmalonic aciduria, cblB type |
| RS2548614345 |
DMXL2
|
Health Risk |
Pathogenic |
— |
| RS2548614401 |
MMAB
|
Health Risk |
Likely pathogenic |
Methylmalonic aciduria, cblB type |
| RS2548615108 |
NALCN
|
Health Risk |
Likely pathogenic |
— |
| RS2548616797 |
MVK
|
Health Risk |
Pathogenic |
Porokeratosis 3, disseminated superficial actinic type |
| RS2548617770 |
MNS1
|
Health Risk |
Pathogenic |
Heterotaxy, visceral |
| RS2548618895 |
MVK
|
Health Risk |
Pathogenic |
Porokeratosis 3, disseminated superficial actinic type |
| RS2548623411 |
MVK
|
Health Risk |
Likely pathogenic |
— |
| RS2548623624 |
MVK
|
Health Risk |
Pathogenic |
Porokeratosis 3, disseminated superficial actinic type |
| RS2548625240 |
MVK
|
Health Risk |
Pathogenic |
Mevalonic aciduria, Porokeratosis 3 |
| RS2548625278 |
MVK
|
Health Risk |
Pathogenic |
Porokeratosis 3, disseminated superficial actinic type |
| RS2548625552 |
MVK
|
Health Risk |
Pathogenic |
Porokeratosis 3, disseminated superficial actinic type |
| RS2548630725 |
MVK
|
Health Risk |
Pathogenic |
Porokeratosis 3, disseminated superficial actinic type |
| RS2548630750 |
MVK
|
Health Risk |
Pathogenic |
Mevalonic aciduria, Hyperimmunoglobulin D with periodic fever |
| RS2548631795 |
MVK
|
Health Risk |
Likely pathogenic |
Mevalonic aciduria, Porokeratosis 3 |
| RS2548631897 |
MVK
|
Health Risk |
Pathogenic |
Porokeratosis 3, disseminated superficial actinic type |
| RS2548631903 |
MVK
|
Health Risk |
Pathogenic |
Porokeratosis 3, disseminated superficial actinic type |
| RS2548631938 |
MVK
|
Health Risk |
Pathogenic |
Mevalonic aciduria, Porokeratosis 3 |
| RS2548631951 |
MVK
|
Health Risk |
Likely pathogenic |
Porokeratosis 3, disseminated superficial actinic type |
| RS2548635761 |
RUNX2
|
Health Risk |
Pathogenic |
— |
| RS2548635868 |
RUNX2
|
Health Risk |
Pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS2548635895 |
RUNX2
|
Health Risk |
Pathogenic |
— |
| RS2548635907 |
RUNX2
|
Health Risk |
Pathogenic |
— |
| RS2548635911 |
RUNX2
|
Health Risk |
Pathogenic |
— |
| RS2548635916 |
RUNX2
|
Health Risk |
Likely pathogenic |
RUNX2-related disorder, RUNX2-related disorder |
| RS2548641225 |
MVK
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS2548642688 |
DMXL2
|
Health Risk |
Pathogenic |
— |
| RS2548642794 |
MVK
|
Health Risk |
Pathogenic |
Mevalonic aciduria, Porokeratosis 3 |
| RS2548642823 |
MVK
|
Health Risk |
Pathogenic |
Mevalonic aciduria, Porokeratosis 3 |
| RS2548642861 |
MVK
|
Health Risk |
Pathogenic |
Mevalonic aciduria, Porokeratosis 3 |
| RS2548650303 |
RUNX2
|
Health Risk |
Pathogenic |
— |
| RS2548650306 |
RUNX2
|
Health Risk |
Pathogenic |
— |
| RS2548650318 |
RUNX2
|
Health Risk |
Pathogenic |
— |
| RS2548650342 |
RUNX2
|
Health Risk |
Pathogenic |
RUNX2-related disorder, RUNX2-related disorder |
| RS2548650498 |
RUNX2
|
Health Risk |
Likely pathogenic |
Cleidocranial dysostosis, Cleidocranial dysostosis |
| RS2548658834 |
EPB41
|
Health Risk |
Likely pathogenic |
Elliptocytosis 1, Elliptocytosis 1 |
| RS2548660142 |
EPB41
|
Health Risk |
Pathogenic |
Elliptocytosis 1, Elliptocytosis 1 |
| RS2548670726 |
OCA2
|
Health Risk |
Likely pathogenic |
— |
| RS2548670988 |
OCA2
|
Health Risk |
Pathogenic |
— |
| RS2548671260 |
OCA2
|
Health Risk |
Pathogenic/Likely pathogenic |
SKIN/HAIR/EYE PIGMENTATION 1, BLUE/NONBLUE EYES |
| RS2548671431 |
OCA2
|
Health Risk |
Pathogenic |
SKIN/HAIR/EYE PIGMENTATION 1, BLUE/NONBLUE EYES |
| RS2548672995 |
OCA2
|
Health Risk |
Pathogenic |
— |
| RS2548676658 |
PCCA
|
Health Risk |
Likely pathogenic |
Propionic acidemia, Propionic acidemia |
| RS2548676740 |
PCCA
|
Health Risk |
Likely pathogenic |
Propionic acidemia, Propionic acidemia |
| RS2548676923 |
PCCA
|
Health Risk |
Pathogenic |
Propionic acidemia, Propionic acidemia |
| RS2548677635 |
PCCA
|
Health Risk |
Pathogenic |
Propionic acidemia, Propionic acidemia |
| RS2548696339 |
AP3B2
|
Health Risk |
Pathogenic |
— |
| RS2548697395 |
AP3B2
|
Health Risk |
Likely pathogenic |
— |
| RS2548698003 |
AP3B2
|
Health Risk |
Pathogenic |
— |
| RS2548698032 |
AP3B2
|
Health Risk |
Pathogenic |
— |
| RS2548699221 |
AP3B2
|
Health Risk |
Pathogenic/Likely pathogenic |
Developmental and epileptic encephalopathy, 48 |
| RS2548703107 |
DMXL2
|
Health Risk |
Likely pathogenic |
— |
| RS2548705861 |
DMXL2
|
Health Risk |
Pathogenic |
— |
| RS2548707698 |
CACNA1H
|
Health Risk |
Pathogenic |
Idiopathic generalized epilepsy, Hyperaldosteronism |
| RS2548708646 |
AP3B2
|
Health Risk |
Pathogenic |
— |
| RS2548711412 |
AP3B2
|
Health Risk |
Pathogenic |
— |
| RS2548711451 |
AP3B2
|
Health Risk |
Pathogenic |
— |
| RS2548711951 |
AP3B2
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, 48 |
| RS2548712141 |
AP3B2
|
Health Risk |
Pathogenic |
— |
| RS2548717189 |
TRPV4
|
Health Risk |
Likely pathogenic |
Charcot-Marie-Tooth disease axonal type 2C, Charcot-Marie-Tooth disease axonal type 2C |
| RS2548718084 |
TRPV4
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Scapuloperoneal spinal muscular atrophy |
| RS2548718983 |
AP3B2
|
Health Risk |
Likely pathogenic |
— |
| RS2548728770 |
TRPV4
|
Health Risk |
Likely pathogenic |
Charcot-Marie-Tooth disease axonal type 2C, Charcot-Marie-Tooth disease axonal type 2C |
| RS2548744790 |
PCDH15
|
Health Risk |
Likely pathogenic |
Autosomal recessive nonsyndromic hearing loss 23, Autosomal recessive nonsyndromic hearing loss 23 |
| RS2548745030 |
PCDH15
|
Health Risk |
Pathogenic |
— |
| RS2548745534 |
DMXL2
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS2548754386 |
TCTN1
|
Health Risk |
Pathogenic |
Joubert syndrome, Meckel-Gruber syndrome |
| RS2548767534 |
TRPV4
|
Health Risk |
Likely pathogenic |
Metatropic dysplasia, Metatropic dysplasia |
| RS2548769622 |
ADAMTS17
|
Health Risk |
Likely pathogenic |
— |
| RS2548779642 |
MYCBP2
|
Health Risk |
Likely pathogenic |
— |
| RS2548785784 |
LIPC
|
Health Risk |
Likely pathogenic |
Abnormal circulating lipid concentration, Abnormal circulating lipid concentration |
| RS2548786346 |
WNK1
|
Health Risk |
Pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS2548787593 |
WNK1
|
Health Risk |
Pathogenic |
Neuropathy, hereditary sensory and autonomic |
| RS2548789633 |
EML1
|
Health Risk |
Likely pathogenic |
Band heterotopia of brain, Band heterotopia of brain |
| RS2548793417 |
PCCA
|
Health Risk |
Pathogenic/Likely pathogenic |
Propionic acidemia, Propionic acidemia |
| RS2548793915 |
PCCA
|
Health Risk |
Likely pathogenic |
Propionic acidemia, Propionic acidemia |
| RS2548794511 |
ADAMTS17
|
Health Risk |
Pathogenic |
— |
| RS2548794622 |
ADAMTS17
|
Health Risk |
Pathogenic |
— |
| RS2548796089 |
TCTN1
|
Health Risk |
Pathogenic |
Joubert syndrome, Meckel-Gruber syndrome |
| RS2548796140 |
WNK1
|
Health Risk |
Pathogenic |
Pseudohypoaldosteronism type 2C, Neuropathy |
| RS2548797919 |
ADAMTS17
|
Health Risk |
Pathogenic |
— |
| RS2548798737 |
WNK1
|
Health Risk |
Pathogenic |
Pseudohypoaldosteronism type 2C, Neuropathy |
| RS2548800660 |
WNK1
|
Health Risk |
Pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS2548804201 |
WNK1
|
Health Risk |
Pathogenic |
Pseudohypoaldosteronism type 2C, Neuropathy |
| RS2548810000 |
CIB2;SH2D7
|
Health Risk |
Likely pathogenic |
Autosomal recessive nonsyndromic hearing loss 48, Ovarian serous cystadenocarcinoma |
| RS2548810898 |
NCF4
|
Health Risk |
Pathogenic |
Granulomatous disease, chronic |
| RS2548815311 |
NFASC
|
Health Risk |
Pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS2548818940 |
HERC2
|
Health Risk |
Likely pathogenic |
Developmental delay with autism spectrum disorder and gait instability, Developmental delay with autism spectrum disorder and gait instability |
| RS2548832773 |
TCTN1
|
Health Risk |
Pathogenic |
Joubert syndrome 13, Joubert syndrome 13 |
| RS2548836529 |
WNK1
|
Health Risk |
Likely pathogenic |
Neuropathy, hereditary sensory and autonomic |
| RS2548847433 |
ADAMTS17
|
Health Risk |
Pathogenic |
— |
| RS2548854465 |
SOX5
|
Health Risk |
Likely pathogenic |
Lamb-Shaffer syndrome, Lamb-Shaffer syndrome |
| RS2548855120 |
SOX5
|
Health Risk |
Likely pathogenic |
Lamb-Shaffer syndrome, Lamb-Shaffer syndrome |